Prospective monitoring for anthracycline cardiotoxicity: an introduction
McGuire, W.P.
Cancer Treatment Reports 62(6): 855
1978
ISSN/ISBN: 0361-5960 PMID: 667858 Document Number: 133491
Document emailed within 1 workday
Related Documents
Lipshultz, S.E.; Sanders, S.P.; Goorin, A.M.; Krischer, J.P.; Sallan, S.E.; Colan, S.D. 1994: Monitoring for anthracycline cardiotoxicity Pediatrics 93(3): 433-437Orditura, M.; De Vita, F.; Ciaramella, F.; Catalano, G. 1994: Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 9(4): 243-248
Wojtukiewicz, M.Z.; Omyła, J.; Kozłowski, L.; Szynaka, B. 2000: Cardiotoxicity of anthracycline Postepy Higieny i Medycyny Doswiadczalnej 54(4): 467-485
Rivero, O.; Mordeglia, F. 1987: Epirubicin: an anthracycline of minor cardiotoxicity Medicina 47(3): 320-321
2008: Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients Prescrire international 17(97): 195
De Leonardis, V.; De Scalzi, M.; Neri, B.; Bartalucci, S.; Cinelli, P. 1987: Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens International Journal of Clinical Pharmacology Research 7(4): 307-311
Okada, Y.; Horikawa, K.; Sano, M. 1997: Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(5): 585-589
Ferrans, V.J. 1978: Overview of cardiac pathology in relation to anthracycline cardiotoxicity Cancer Treatment Reports 62(6): 955-961
McGovren, J.P.; Neil, G.L.; Denlinger, R.H.; Hall, T.L.; Crampton, S.L.; Swenberg, J.A. 1979: Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent Cancer Research 39(12): 4849-4855
Ali, A.A.S.; Al-Mudhafar, A.M.J. 2011: Prediction of anthracycline induced cardiotoxicity: study of thirty-one Iraqi adult patients Gulf Journal of Oncology 10: 33-39
Lemez, P.; Maresová, J. 1996: Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias Neoplasma 43(6): 417-419
Liu, L.; Liu, Z-zhe.; Liu, Y-ye.; Zheng, Z-dong.; Liang, X-feng.; Han, Y-ling.; Xie, X-dong. 2013: Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 35(12): 936-940
Patel, C.D.; Balakrishnan, V.B.; Kumar, L.; Naswa, N.; Malhotra, A. 2010: Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity? Hellenic Journal of Nuclear Medicine 13(3): 233-237
Okuma, K.; Ariyoshi, Y.; Ota, K. 1988: Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(6): 1893-1900
Inoue, K.; Hiura, A. 2003: Introduction: development and prospective of regenerative medicine Nihon Rinsho. Japanese Journal of Clinical Medicine 61(3): 363-369
Holzmann, M. 1973: Arrhythmias. Introduction: retrospective and prospective view Die Medizinische Welt 24(26): 1073-1075
Sumikawa, K. 2009: Usefulness and limitation of new circulatory monitoring: introduction Masui. Japanese Journal of Anesthesiology 58(7): 818-819
Lin, C-Wei.; Wang, S-Pei. 2016: Introduction of Hemodynamic Monitoring in Critical Care Units Hu li za zhi journal of nursing 63(1): 117-124
Zappa, M. 2008: National Centre for Screening Monitoring. Sixth report. Introduction Epidemiologia e Prevenzione 32(2 Suppl. 1): 5-6
Ermilova, A.P.; Margulis, U.I.; Khrushch, V.T. 1973: Methodical problems in individual monitoring of internal radiation due to introduction of Po 210 into the body Gigiena i Sanitariia 38(9): 62-65